TY  - GEN
AU  - Ruan,Jia
AU  - Martin,Peter
AU  - Shah,Bijal
AU  - Schuster,Stephen J
AU  - Smith,Sonali M
AU  - Furman,Richard R
AU  - Christos,Paul
AU  - Rodriguez,Amelyn
AU  - Svoboda,Jakub
AU  - Lewis,Jessica
AU  - Katz,Orel
AU  - Coleman,Morton
AU  - Leonard,John P
TI  - Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
SN  - 1533-4406
PY  - 2015///1112
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Exanthema
KW  - chemically induced
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Induction Chemotherapy
KW  - Intention to Treat Analysis
KW  - Lenalidomide
KW  - Lymphoma, Mantle-Cell
KW  - drug therapy
KW  - Maintenance Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Neutropenia
KW  - Quality of Life
KW  - Rituximab
KW  - Survival Analysis
KW  - Thalidomide
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1505237
ER  -